054670 — Daehan Nupharm Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩95bn
- KR₩159bn
- KR₩202bn
- 63
- 79
- 10
- 51
Annual cashflow statement for Daehan Nupharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9,927 | 15,694 | 24,317 | 12,542 | 15,468 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 33,334 | 11,027 | 6,010 | 10,010 | 10,218 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12,888 | -13,467 | -19,302 | -13,466 | -10,837 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 13,546 | 16,583 | 14,253 | 12,567 | 18,947 |
| Capital Expenditures | -9,794 | -10,553 | -3,514 | -9,930 | -34,256 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -6,992 | -3,372 | -3,411 | -2,373 | 5,133 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -16,786 | -13,925 | -6,926 | -12,303 | -29,123 |
| Financing Cash Flow Items | — | 20 | — | 50 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,390 | -2,725 | -1,383 | -2,232 | 20,510 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,854 | -66.3 | 5,853 | -1,954 | 10,524 |